Diagenode is a biopharmaceutical company that develops and commercializes novel epigenetic therapeutics for the treatment of cancer diseases.
Business Model:
Revenue: $20M
Employees: 51-200
Address: Rue Bois Saint-Jean, 3
City: Seraing
State: liège
Zip: 4102
Country: BE
Diagenode is a biopharmaceutical company that develops and commercializes novel epigenetic therapeutics for the treatment of cancer diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2016 | Equity | $8.5M |
Société Régionale d'Investissement de Wallonie OBI SA Capricorn Health-tech Fund NV |
6/2016 | Venture Round | $0 |
Capricorn Partners OBI SA S.R.I.W. Epimède SA Capricorn Partners Capricorn Partners OBI SA S.R.I.W. Epimède SA Capricorn Partners |
6/2016 | Venture Round | 4 | $8.5M |
Capricorn Partners OBI SA S.R.I.W. Epimède SA Capricorn Partners Capricorn Partners OBI SA S.R.I.W. Epimède SA Capricorn Partners |
---|
Announced Date | Name | Price |
---|---|---|
8/2018 | NXT-Dx |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|